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Objective: To evaluate the effect of assisted reproductive techniques on the incidence of monozygotic
twins (MZT) and the associated pregnancy outcomes.
Materials and methods: This was a retrospective study of all in vitro fertilization (IVF)/intracytoplasmic
sperm injection (ICSI) cycles with MZT pregnancies in our center from January 2001 to December 2011.
The diagnosis of MZT pregnancies with their respective placental conﬁgurations was based on the results
of ultrasonographic examinations performed during either the ﬁrst or second trimester. The treatment
characteristics and outcomes of each IVF cycle were recorded and stored in a computer database.
Results: A total of 17 cycles with MZT pregnancies were identiﬁed, resulting in an overall incidence of
MZT of 1.3%. The incidence of MZT for women aged <35 years and 35 years were 1.5% and 0.8%,
respectively (p ¼ 0.319). The incidence was not signiﬁcantly different between ICSI and non-ICSI cycles
(1.4% vs. 1.0%; p ¼ 0.620). In addition, the incidence was not increased in the assisted hatching (AH) group
compared to those without AH (0.9% vs. 2.1%; p ¼ 0.103). Finally, cycles with embryo transfer at the
blastocyst stage had an MZT incidence that was not signiﬁcantly different from those transferred at the
cleavage stage (1.4% vs. 1.3%, respectively; p ¼ 1.000). The incidence of each type of chorionicity,
dichorionicediamniotic, monochorionicediamniotic, and monochorionicemonoamniotic, was 33.3%,
46.7%, and 20.0%, respectively. A total of 11 of 39 (28%) monozygotic babies and 16 of 19 (84%) coexisting
heterozygotic babies were born alive.
Conclusion: Until deﬁnite conclusions are drawn from larger trials, patients receiving IVF should not be
overly concerned about the increase in MZT risk when proceeding to various assisted reproductive
procedures (i.e., ICSI, AH, and blastocyst transfer). However, there is some evidence that the incidence of
monochorionicemonoamniotic twins may be signiﬁcantly increased after IVF/ICSI cycles. Patients should
be informed about the possible obstetric complications regarding this rare type of MZT.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Monozygotic twinning (MZT) occurs rarely in natural concep-
tion, with an estimated overall incidence of 0.4e0.45% [1,2]. Unlike
dizygotic twinning, in which the incidence varies among different
races, monozygotic twinning is evenly distributed in all populationsnd Gynecology, Chang-Gung
oyuan 333, Taiwan.
ang).
bstetrics & Gynecology. Publishedaround the world [3]. The use of assisted reproductive techniques
(ART) has been suggested to be associated with an increased
occurrence of MZT, which is approximately 1.5% [1,4,5]. However,
the actual ART-related incidence is obscured by multiple embryo
transfer and early embryonic demise. Several previously proposed
factors contributing to the increased incidence of MZT in ART
include ovarian stimulation, intracytoplasmic sperm injection
(ICSI), assisted hatching (AH), and embryo culture. However, the
exact mechanism that leads to the association between ART and
MZT is still unclear and needs further investigation.by Elsevier Taiwan LLC. All rights reserved.
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embryos. If the cleavage of the zygote occurs later than the 4th day
after fertilization, monochorionic twins (with or without the
sharing of placenta), monoamniotic twins, or even conjoined twins
may develop. MZT is associated with several signiﬁcant obstetric
complications, including preterm labor, intrauterine growth re-
striction, and fetal death. Twinetwin transfusion syndrome (TTTS)
occurs in approximately 9e15% of monochorionic twins [6,7], and
the neurologic sequelae of the surviving twins generate further
concerns. With the recent trend of the increasing use of ART, pre-
conception counseling about the possibility of monozygotic twins
becomes crucial prior to an ART protocol. Furthermore, early
detection of the zygosity by transvaginal sonography in the ﬁrst or
early second trimester should be routinely performed in clinical
practice.
In this retrospective study, we report all MZT gestations from
in vitro fertilization (IVF) cycles performed between 2000 and 2011
in our fertility center. The available laboratory data, treatment
protocols, and pregnancy outcomes were reviewed accordingly.
The objective was to identify any association between the ART
procedures and the incidence of MZT pregnancy.
Materials and methods
This study consists of all IVF/ICSI cycles with embryo transfer
performed in our center from January 2001 to December 2011.
Patients were assigned to either the long protocol (downregulation
protocol) using a GnRH agonist (Lupron; Takeda, Osaka, Japan) or
the GnRH antagonist (Cetrotide; Serono, Geneva, Switzerland)
protocol according to their fertility evaluations and/or previous
treatment responses. Both protocols combined the use of recom-
binant gonadotropin injections (Gonal-F; Industria Farmaceutica,
Serono, Italy; or Puregon; N.V. Oganon, Oss, The Netherlands)
initiating on Day 2e3 of the stimulation cycle. The dosage of re-
combinant gonadotropinwas adjusted according to serum estradiol
(E2) levels and follicular growth monitored by transvaginal ultra-
sonography. Final oocyte maturation was triggered by 10,000 IU of
urinary human chorionic gonadotropin (Pregnyl; MSD, Haarlem,
The Netherlands) when therewere two ormore follicles larger than
1.7 cm. Oocyte retrieval was performed 36 hours after human
chorionic gonadotropin administration under the guidance of
transvaginal ultrasonography. Progesterone supplementation
began on the day of oocyte retrieval and continued until a fetal
heartbeat was conﬁrmed.
After serial washing, each oocyte recovered was maintained at
37C in a separate drop of fertilization medium (Cook IVF, Brisbane,
QL, Australia) equilibrated with 6% CO2 in air. Insemination was
carried out either through the conventional IVF procedure or ICSI
based on the results of semen analysis. The zygotes were examined
for the presence of pronuclei and polar bodies at 18e21 hours after
insemination. Zygotes with two pronuclei were cultured at 37C in
a separate drop of cleavage culture medium equilibrated with 6%
CO2 in air until Day 3. Embryos were assessed daily on develop-
mental rate and morphologic appearances to determine the length
of culture. If embryos were cultured beyond Day 3, blastocyst cul-
ture medium (Cook IVF) was used. The best quality embryos were
selected for transfer. These embryos were selectively treated with
AH on the day of embryo transfer. We used laser quarter thinning of
the zona pellucida (ZP), as described previously [8,9], as our method
of AH.
Routine transvaginal ultrasonographic examinations were ar-
ranged for the 6th gestational week or 7th gestational week for
patients with a positive urinary pregnancy test result. The following
diagnostic criteria were used to determine monozygotic pregnan-
cies: the number of fetal poles exceeded the number of embryostransferred or more than one fetal pole was identiﬁed in a single
gestational sac. Follow-up obstetric ultrasonographic examinations
were arranged at 10e14 weeks of gestation to conﬁrm fetal
viability, chorionicity, and fetal sex. Chorionicitywas determined by
the presence of either a “T-sign” (which signiﬁes monochorionic
twins) at the intertwin membrane-placental junction or a “l-sign”
(which suggests dichorionic twins) [10], whereas fetal sex was
identiﬁed by checking for the sagittal sign, as described previously
[11,12]. All ultrasonographic examinations were performed bywell-
experienced ultrasonographic technicians, and all images were
reviewed by gynecologists to conﬁrm the diagnosis. The treatment
characteristics and outcomes of each IVF cycle were recorded and
stored in a computer database. Chi-square tests were used to
analyze the effect of each proposed risk factor on the incidence of
MZT. A p value <0.05 was considered statistically signiﬁcant.
Results
The total number of IVF cycles from January 2001 to December
2011with a positive pregnancy result was 1338, inwhich 17 pairs of
MZTwere identiﬁed, resulting in an overall incidence ofMZTof 1.3%
in this study. All 17 pairs of MZT resulted from the transfer of fresh
embryos. Only one pair of MZT resulted from the use of donated
oocytes, and the rest of the MZT pairs resulted from embryo
transfer of autologous oocytes. We did not analyze these two
groups separately because the number of MZT pairs resulting from
donated oocytes was small. The summary of patient characteristics,
treatment protocols, and chorionicities of the 17 MZT pregnancies
is shown in Table 1, and the proposed MZT risk factors with their
respective incidences of MZT gestation are summarized in Table 2.
The mean maternal age of MZT pregnancies was 32.1 years. To
analyze the effects of maternal age on the incidence of MZT preg-
nancy, we compared IVF cycles performed in women aged <35
years with women 35 years. The results showed that the inci-
dence of MZT pregnancy was higher in cycles performed in women
aged <35 years, although the difference was not statistically sig-
niﬁcant (1.5% vs. 0.8%, respectively; p ¼ 0.319).
The effect of ICSI on the incidence of MZT pregnancy was
analyzed. There were 853 fresh IVF cycles with positive pregnancy
results in which ICSI was performed. Twelve ICSI cycles (1.4%)
developed MZT gestations. For fresh IVF cycles without ICSI, the
incidence of MZT was 1.0%. However, the difference was not sta-
tistically signiﬁcant (p ¼ 0.620). We also examined the effect of AH
on the incidence of MZT pregnancy, but the results showed no in-
crease in MZT incidence in the AH group compared to those
without AH (0.9% vs. 2.1%).
The inﬂuence of embryo culture length on the incidence of MZT
pregnancy was also reviewed. The incidence of MZT pregnancy in
the Day 5 group was 1.4% (2 out of 151), which is not signiﬁcantly
different from the 1.3% (15 out of 1191) incidence in the cleavage
stage group.
The chorionicity of MZT pregnancies was determined via
transvaginal ultrasonographic examinations performed in the ﬁrst
and/or second trimester (Figure 1). Two MZT gestations had un-
determined chorionicities due to early fetal demise. Ten (67%) of
the MZT pairs with known chorionicities were monochorionic,
whereas ﬁve (33%) were dichorionic. Of the monochorionic MZT
pregnancies, seven (70%) were diamniotic and three (30%) were
monoamniotic.
The obstetric outcomes of all 17 cases with MZT pregnancies are
summarized in Table 3. Fourteen cases resulted in at least one live
birth, including thosewith coexisting heterozygotic infant (s). In six
of these cycles, at least one monozygotic baby was born alive. A
coexisting viable heterozygotic infant was delivered at the same
time in two cases. Only one pair of monochorionicemonoamniotic
Table 1
Summary of patient characteristics, treatment protocols, and chorionicities.
Case no. Maternal age (y) Type of infertility Etiology IVF protocol ICSI AH Day of ET No. of embryos transferred OHSS Chorionicity
1 33 Secondary Tubal factor Long agonist   3 5  DCDA
2 28 Primary Male factor Long agonist þ  3 6 þ MCDA
3 29 Primary Male factor Long agonist þ þ 3 5  MCDA
4 32 Primary Tubal factor Long agonist  þ 3 3  MCDA
5 32 Primary Unexplained Long agonist þ  2 2  DCDA
6 35 Secondary Tubal factor Long agonist   3 3  DCDA
7 28 Primary Tubal factor Long agonist   2 3 þ MCMA
8 31 Secondary Ovulatory factor Long agonist  þ 2 3  MCDA
9 32 Secondary Ovulatory factor Long agonist þ þ 3 4  MCDA
10 33 Primary Unexplained Long agonist þ þ 2 4  MCMA
11 31 Primary Combined Antagonist þ þ 3 3  MCMA
12 36 Primary Male factor Antagonist þ þ 3 3  Unknown
13 37 Primary Male factor Long agonist þ þ 3 4  Unknown
14 33 Primary Male factor Long agonist þ þ 2 2  DCDA
15 34 Secondary Tubal factor Antagonist þ  5 4  DCDA
16 30 Primary Ovulatory factor Antagonist þ  4 3  MCDA
17 41 Primary Ovulatory factor Antagonist þ  5 3  MCDA
AH ¼ assisted hatching; DCDA ¼ dichorionicediamniotic; ET ¼ embryo transfer; ICSI ¼ intracytoplasmic sperm injection; MCDA ¼ monochorionicediamniotic;
MCMA ¼ monochorionicemonoamniotic; OHSS ¼ ovarian hyperstimulation syndrome.
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case developed monozygotic triplets, and all three babies were
delivered alive (Case 17).
In the three cases in which there was no live birth, one had a
coexisting singleton and resulted in triplet fetal deaths during the
ﬁrst trimester. The other two cases with only MZT fetuses acquired
TTTS; both were monochorionicediamniotic (MCDA) twins and
each received an elective termination at 26 weeks and 30 weeks of
gestation, respectively. A total of nine cases received an elective
fetal reduction, whereas spontaneous fetal loss occurred in six.
In summary, a total of 58 fetuses developed from 17 IVF cycles
with MZT pregnancies. Thirty-nine were monozygotic and 19 were
coexisting singletons or twins. Eleven of 39 (28%) monozygotic
babies and 16 of 19 (84%) coexisting heterozygotic fetuses were
born alive.
Discussion
Monozygotic twin pregnancies have an increased risk of ob-
stetric complications and poor pregnancy outcomes. Although it is
a rare event, its incidence had been reported in previous studies to
increase by as much as four-fold as a result of ART procedures
[1,4,5,13,14]. The trend towards late marriage and delaying
conception has resulted in the increased practice of ART in many
countries worldwide. This phenomenon is even more markedly
demonstrated in Taiwan by the increase of total IVF cycles per-
formed from 2001 to 2010 (from 6458 to 11,513, a 78% increase).
The percentage of live births resulting from IVF cycles has also
increased from 0.8% to 1.8% [15]. Therefore, MZT gestations may
become an issue as a growing number of ART practices persist.
Unlike dizygotic multiple pregnancies, which can be easily
explained by multiple ovulations or multiple embryo implanta-
tions, the actual mechanism resulting in the development ofTable 2
Summary of proposed monozygotic twinning (MZT) risk factors with their respec-
tive MZT incidences.
Proposed MZT risk factor MZT incidence (%) p
With risk factor Without risk factor
Maternal age > 35 y 0.82 1.53 0.319
ICSI 1.40 1.02 0.620
Assisted hatching 0.94 2.10 0.103
Day-5 transfer 1.35 1.26 1.000
ICSI ¼ intracytoplasmic sperm injection.monozygotic multiple pregnancies remains uncertain. It seems
obvious that themoment of embryonic cleavage plays an important
part in the outcome. However, there is not yet a single theory
explaining themechanism of zygotic splitting that is responsible for
the increased incidence of MZT as a result of various assisted
reproduction methods.
Several aspects of ART techniques have been discussed previ-
ously in an attempt to link their associations with MZT incidence,
including maternal age, ICSI, AH, PGD, and length of embryo cul-
ture. In the current study, the overall incidence of MZT pregnancy
was 1.3%, a result comparable to previously reported data, which
was approximately three times higher than a rate of 0.4% from
natural conceptions [1,16e18].
Previous reports have suggested that advanced maternal age
increases the incidence of spontaneousMZT pregnancies [16]. It has
been proposed that the average thickness of the ZP gradually de-
creases with increasing maternal age [19e22], which may alter the
normal hatching process, for instance, the splitting of blastocyst
during its protrusion due to multiple sites of zona lysis [23].
However, two recent studies reported outcomes that conﬂict with
the concept of advanced maternal age being a risk factor [24,25].
The correlation between zona properties and maternal age was
further challenged by two other recent published reports [26,27].
Interestingly, our data also showed a trend towards a higher inci-
dence of MZT pregnancies in women aged <35 years compared to
those aged 35 years (1.5% vs. 0.8%; p ¼ 0.319).
The use of micromanipulation in ART has been frequently linked
with the development of MZT. The proposed mechanism for this
link is related to ZP damage that creates gaps, which induce her-
niation in the blastomere membranes, causing embryo splitting.
Previous reports compared MZT incidences between ZP manipu-
lation procedures such as ICSI or AH and conventional IVF.
Although some studies found an increased incidence of MZT
pregnancy after ZP manipulation [2,23,28e30], many others did
not observe this association [14,18,31e34]. In the current study, we
also failed to observe signiﬁcant difference in MZT incidence be-
tween IVF with zona manipulation and conventional IVF. The
contradictory results between the various studies may be due to
the following reasons. First, most of the studies, including the
current report, were carried out as retrospective reviews. The sig-
niﬁcant heterogeneity between these study groups makes it difﬁ-
cult to compare and analyze the results objectively. Furthermore,
there were various reported techniques of performing ZP manip-
ulation, and the procedures used in the earlier reports might have
Fig. 1. Summary of documented chorionicity of monozygotic twin (MZT) pregnancies.
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The question of whether different techniques of micromanipula-
tion procedures can affect the incidence of MZT pregnancy
remained to be answered. Finally, there may exist unknown
mechanisms during IVF procedures, other than ZP manipulation,
that are involved in embryo splitting.
The other factor being discussed that may affect the MZT
pregnancy incidence is the stage at which the embryo is trans-
ferred. With the introduction of sequential culture media, blasto-
cyst transfer has gained increasing popularity over the past decade
[35]. It has long been accepted that transferring an embryo at the
blastocyst stage enhances implantation rates. In this way, the
number of transferred embryos can be reduced to lower the risk of
multiple pregnancies without decreasing the pregnancy rate [36].
Nevertheless, many studies have reported an increased risk of MZT
pregnancies after a blastocyst transfer compared with a cleavage
stage embryo transfer [24,29,32,37e39]. This increase has been
explained by several mechanisms, including prolonged culture
time [40], culture media composition [41,42], and the experience of
laboratory embryologists [37,43]. By contrast, other recent studies
did not ﬁnd an increase in MZT pregnancy rate after blastocyst
transfer [44,45]. Our ﬁndings also showed no signiﬁcant difference
inMZT risk between the two stages of embryo transfer. Again, many
of these studies were small series studies, which resulted in great
variations in MZT rates. Further larger trials are required to inves-
tigate whether the stage at which the embryo is transferred has an
impact on MZT rate.Table 3
Summary of pregnancy outcomes.
Case no. Monozygotic twins/triplets Coexisting heterozygotic
infant (s)
Delivery
method
G
a
1 Fetal reduction  2 Fetal reduction  1
Alive  2
Cesarean 3
2 Expired  2 0 Vaginal 3
3 Expired  2 0 Vaginal 2
4 IUFD  3 0 Vaginal 1
5 Fetal reduction  2, Alive  2 0 Cesarean 3
6 Fetal reduction  2 Alive  2 Cesarean 3
7 Fetal reduction  2 Alive  2 Cesarean 3
8 Alive  2 0 Cesarean 3
9 Fetal reduction  2 Alive  1 Cesarean 2
10 Fetal reduction  4 Alive  2 Cesarean 3
11 Alive  2 Alive  1 Cesarean 3
12 Fetal reduction  2 Alive  1 Cesarean 4
13 Alive  1, IUFD  1 Alive  1 Cesarean 3
14 Alive  1, IUFD  1 Alive  1 Cesarean 3
15 Fetal reduction  2 Alive  2 Cesarean 3
16 Fetal reduction  2 Alive  1 Vaginal 3
17 Alive  3 0 Cesarean 3
IUFD ¼ intrauterine fetal death; TTTS ¼ twinetwin transfusion syndrome.To evaluate the obstetric outcomes of MZT pregnancies, we
discuss not only the effect of IVF procedures on the incidence of
MZT pregnancy but also the membrane conﬁguration of each MZT
cycle. In the current study, the percentage of each type of chorio-
nicity (dichorionicediamniotic, MCDA, and MCMA) was 33.3%,
46.7%, and 20.0%, respectively. In particular, the incidence of MCMA
twins was much higher than those from spontaneous MZT (1e2%)
[46]. This ﬁnding is similar to the result of a previous study that
reported the signiﬁcantly increased incidence ofMCMA twins (37%)
after ART treatments [13]. Although the relative occurrence of each
type of chorionicity of ART-derived MZT requires further support-
ing data, the results raise concerns that the obstetric risk may be
elevated in women receiving ART procedures.
MCMA twins are well known for their high risk of cord entan-
glement and TTTS. As a consequence, previous reports have
emphasized the high perinatal loss rate in MCMA twins (range,
19e44%) [47e50]. Fortunately, the three cases of MCMA twin
pregnancies in our study had relatively good outcomes. Two
received elective fetal reduction and resulted in live birth deliveries
of coexisting heterozygotic twins. One had a coexisting singleton
delivered alive with the MCMA twins, which made them the only
surviving MCMA twins in this study. By contrast, the only two cases
with TTTS had MCDA twins. Both received an elective termination
during the early third trimester due to poor fetal conditions.
In conclusion, this study represents the ﬁrst single-center
experience that analyzes the relationship between MZT incidence
and ART in Taiwan. In addition, the pregnancy outcomes were alsoestational
ge (wk)
Birth weight (g) Sex Complication At least 1
live birth
4 1540, 2080 F, M þ
0 1120/899 F/F TTTS 
6 695/775 Ambiguous TTTS 
1 10/5/5 Ambiguous 
1 1350/1610 M, F þ
6 2550, 1865 F, F þ
4 2020, 1850 M, F þ
2 2260/2250 M/M þ
7 1039 F Maternal pulmonary
edema
þ
5 2390, 950 M, M þ
4 1745/1670, 1830 M/M, F þ
0 3140 M þ
5 2555, 2375 F, F þ
6 2750, 2190 F, M þ
6 2070, 2095 F, M þ
8 2890 M þ
1 1740/1285/1560 M/M/M þ
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the rate of MZT is higher in women receiving ART compared with
that of spontaneous MZT. Our study also agreed with recent ﬁnd-
ings thatMZT pregnanciesmay be associatedwith younger women.
However, we did not ﬁnd a signiﬁcant increase in theMZT rate from
IVF cycles withmicromanipulation or blastocyst transfer. Lastly, the
incidence ofMCMA twins (which is believed to be the rarest form of
MZT) appeared to increase signiﬁcantly after ART.
There are several limitations to this study that must be dis-
cussed. Similar to many of the previous studies, the current study
was carried out through a retrospective review. In addition,
different age groups might receive different ART, which makes
objective comparisons difﬁcult. Furthermore, the diagnosis of MZT
was based on the ﬁndings of the ﬁrst or second trimester ultra-
sound, which identiﬁed those with a number of fetuses exceeding
the number of embryos transferred. The conﬁrmation of MZT
through neonatal DNA analysis was not performed in any of the
cycles. This fact may lead to the underestimation of MZT, as some
MZT might have been misinterpreted as fraternal twins in cases of
dichorionicediamniotic twins. Lastly, this study was conducted
based on a single center experience, which provided us with a
relatively small sample size. The rare occurrence of MZT incidence
also resulted in the paucity of cases of interest. Further larger trials
are required to draw solid conclusions on this topic.
MZT has long been associated with the use of ART. Based on the
ﬁndings of current study and previous studies, patients receiving
IVF should not be overly concerned about the increase in MZT risk
when proceeding to various other ART (i.e., ICSI, AH, and blastocyst
transfer). However, the incidence of MCMA twins may be signiﬁ-
cantly increased after IVF/ICSI cycles. We suggest the initiation of
national scale multicenter trials to assess the relative risks of each
proposed contributing factor of MZT. Through a better under-
standing of the relationship between ART and MZT, we will be able
to reduce the incidence of MZT and thus lower the potential ob-
stetric risks in future IVF cycles.Conﬂicts of interest
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